We are working closely with Rice University to monitor the continued impact of the COVID-19 on our community. The health and safety of our guests and staff are our top priority. All gatherings at Baker Hall through April 30 have been canceled. A current list of scheduled online events is available at bakerinstitute.org/events and will be updated with new webcasts and webinars. Please refer to emergency.rice.edu/coronavirus for additional information and updates.

The Impact of Comparative Effectiveness Research on the U.S. Health Care System

In the 12 months since President Barack Obama took office, health care reform has been a major concern for both the White House and Congress. One part of the proposed overhaul is an emphasis on quality care at reasonable prices. This involves continued and increased research -- known as comparative effectiveness research -- on the outcomes and effectiveness of different drugs, therapies and procedures. Comparative effectiveness research directly compares existing health care interventions to determine which procedures work best for various patient populations and which pose the greatest benefits and harms.

This discussion is the second event in the Medicine, Research and Society Public Policy Issues Series, a joint project between the Baker Institute Science and Technology Policy Program and The University of Texas M. D. Anderson Cancer Center. Additional sponsors for this event include the Baker Institute Health Policy Forum and the Rice University Institute of Biosciences and Bioengineering.

CER Event

Speaker Kirstin Matthews

View all speakers


Wed, Feb. 24, 2010
7:45 a.m. - 9:30 a.m.
(GMT-0500) America/Chicago


Rice University's Baker Institute